SZSE Ticker: 002166

Guilin Layn Natural Ingredients Corp.

桂林莱茵生物科技股份有限公司

莱茵生物

LAYN

Listing Date: 2007-09-13

Board: SME

Industry Classification: Manufacturing

Qianjin vinesu is on fire! Qianjin Pharmaceutical and many other companies quickly clarified_ Oriental Fortune Net

Post date May 17, 2022 — 09:35 Post Lock

The concept stock of Qianjintansu blows out, and many companies clarify that it is "Oolong hype"

Post date May 17, 2022 — 03:25 Post Lock

Qianjin Pharmaceutical does not have Qianjin Tensudo to clarify the connection! Note that the inhibition data of 15,000 times the risk is only the result of in vitro experiments

Post date May 16, 2022 — 23:09 Post Lock

Qianjin Pharmaceutical has no Qianjin phylloxacin, and many companies clarify the relationship! Pay attention to the risks, the inhibition data of 15,000 times are only the results of in vitro experiments.

Post date May 16, 2022 — 23:07 Post Lock

The concept of a thousand golden vines was born, and it is very popular! A concept stock pulls 2 "30cm" daily limit in a row, stock friends: Fengshui turns, it seems that you are the leading investor diary-Stock Channel-Hexun.com

Post date May 16, 2022 — 20:29 Post Lock

The concept stock of "Qianjintiansu" has become popular, and it takes a few steps from the research compound to the finished drug

Post date May 16, 2022 — 17:30 Post Lock

The policy is favorable for traditional Chinese medicine enterprises to welcome a "good start" in the first quarter _ Oriental Fortune Net

Post date May 10, 2022 — 13:11 Post Lock

Rhine Bio: Foreign exchange fluctuations have a certain impact on export-oriented companies, and the depreciation of the RMB exchange rate is conducive to the company's export business

Post date May 6, 2022 — 20:20 Post Lock

New Fortune Analyst Annual Meeting and High-end Capital Market Summit of Huangpu District Guangzhou Development Zone kicks off-News Channel-Hexun.com

Post date April 22, 2022 — 21:00 Post Lock

Chinese medicine can make a difference! Zuoli Pharmaceutical's performance has continuously increased significantly, and R&D investment needs to be increased.

Post date April 21, 2022 — 10:07 Post Lock

The main capital of 4.355 billion yuan is withdrawn from the pharmaceutical and biological sector today – yqqlm

Post date April 20, 2022 — 18:36 Post Lock

4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm

Post date April 19, 2022 — 19:09 Post Lock

4.266 billion yuan of funds flowed out of pharmaceutical and biological stocks today jqknews

Post date April 19, 2022 — 18:12 Post Lock

Rheinbiology: The company's plant extraction technology is at the leading level in the industry, and the current capacity reserve is sufficient

Post date April 18, 2022 — 11:15 Post Lock

Rhine Bio: The company's plant extraction business has established global sales channels, and the United States is one of the most important markets

Post date April 18, 2022 — 11:11 Post Lock

Rheinland Biotech (002166): Resolution of the Board of Directors CFi.CN China Financial Network

Post date April 15, 2022 — 03:55 Post Lock

Rheinland Biotech (002166): Resolution of the Supervisory Board CFi.CN China Financial Network

Post date April 15, 2022 — 03:46 Post Lock

Rhine Biotech (002166): Notice of Annual General Meeting of Shareholders- CFi.CN Zhongcai Network

Post date April 15, 2022 — 03:46 Post Lock

Rheinland Biotech (002166): Annual Report of Independent Directors CFi.CN

Post date April 15, 2022 — 03:45 Post Lock

Rhine Biotech (002166): Special Explanation on the Use of Annual Raised Funds- CFi.CN Zhongcai Network

Post date April 15, 2022 — 03:45 Post Lock

Want to see more data? Registered subscribers can see all the data.